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Abstract: Preproglucagon (PPG) neurons produce glucagon-like peptide-1 (GLP-1) and occur primarily 
in the nucleus tractus solitarius (NTS). GLP-1 affects a variety of central autonomic circuits, including 
those controlling the cardiovascular system, thermogenesis, and most notably energy balance. Our 
immunohistochemical studies in transgenic mice expressing YFP under the control of the PPG 
promoter showed that PPG neurons project widely to central autonomic regions, including brainstem 
nuclei. Functional studies have highlighted the importance of hindbrain receptors for the anorexic 
effects of GLP-1. 
In this study, we assessed YFP innervation of neurochemically-identified brainstem neurons in 
transgenic YFP-PPG mice. Immunoreactivity for YFP plus choline acetyltransferase (ChAT), tyrosine 
hydroxylase (TH) and/or serotonin (5-HT) were visualised with two- or three-colour 
immunoperoxidase labelling using black (YFP), brown and blue-grey reaction products. 
In the dorsal motor nucleus of the vagus (DMV), terminals from fine YFP-immunoreactive axons closely 
apposed a small proportion of ChAT-positive and rare TH-positive/ChAT-positive motor neurons, 
mostly ventral to AP. YFP-immunoreactive innervation was virtually absent from the compact and 
loose formations of the nucleus ambiguus. In the NTS, some TH-immunoreactive neurons were closely 
apposed by YFP-containing axons. In the A1/C1 column in the ventrolateral medulla, close appositions 
on TH-positive neurons were more common, particularly in the caudal portion of the column. A single 
YFP-immunoreactive axon usually provided 1-3 close appositions on individual ChAT- or TH-positive 
neurons. Serotonin-immunoreactive neurons were most heavily innervated, with the majority of raphé 
pallidus, raphé obscurus and parapyramidal neurons receiving several close appositions from large 
varicosities of YFP-immunoreactive axons. 
These results indicate that GLP-1 neurons innervate various populations of brainstem autonomic 
neurons. These include vagal efferent neurons and catecholamine neurons in areas linked with 
cardiovascular control. Our data also indicate a synaptic connection between GLP-1 neurons and 5-HT 
neurons, some of which might contribute to the regulation of appetite. 
 
 
Response to Reviewers: We thank the Reviewers for their thorough evaluation of our manuscript and 
their helpful suggestions, which have improved the manuscript significantly. We now provide a revised 
manuscript that incorporates the suggestions of the Reviewers and hope that it is now acceptable for 
publication in Neuroscience. 
 
Below are our detailed responses to each point raised by the Reviewers: 
 
 
REVIEWER #1,  
 
1)  “The presentation of the data is inadequate. The data are important and the authors stress several 
times that the powerful immunohistochemistry of YFP has enabled them to view the complete 
brainstem PPG innervation. If this is indeed the case - and I must admit that the staining shown in Figs 
1-3 is really clear - they should help the reader in understanding the full extent of this innervation. This 
could be done in a series of line-drawings through the caudal brainstem (e.g. using images from mouse 
brain atlases) illustrating the location of 5HT, ChAT and TH cells (could even be illustrated on the same 
images) and the degree of innervation by PPG/YFP fibers. It is very difficult from the rather selected 
illustrations to get a full picture of the brainstem innervation and the extent to which the different 
phenotypically labeled neurons are contacted by the YFP fibers.” 
 
-  We have added three new figures to the revised manuscript (Figures 2, 4 and 6).  The new figures 
show maps of the distributions of TH-immunoreactive, ChAT-immunoreactive and 5-HT-
immunoreactive neurons in sections through various regions of the medulla. The maps indicate which 
neurons receive close appositions from YFP-immunoreactive varicosities and which do not and include 
counts of the neurons with and without appositions. The inclusion of three new figures in the revised 
manuscript has required us to add a section to Experimental Procedures describing how the maps 
were constructed and neurons were counted (section 2.2.1, “Mapping neurochemically-identified 
brainstem neurons that received or lacked YFP-immunoreactive innervation” on pages 10 and 11).  
      These new figures and the quantitative data have substantially strengthened the manuscript.  We 
thank Reviewer #1 for suggesting that we include such figures. 
 
2)  “The data are heavily overinterpreted: The two last highlights are overstatements that are not 
supported by the data”:  
      “The first statement is not supported by the data - and it certainly does not explain the 
cardiovascular effects of GLP-1 - well it could potentially be a route by which GLP-1 influences the 
cardiovascular system, but the authors do not know if this is an important pathway.” 
      “The second statement is also heavily overinterpretation. Yes - GLP-1 is involved in appetite 
regulation and so is the serotonergic system, but if the two are connected and if the serotonergic 
neurons contacted by YFP fibers are involved in satiation (or one of the other multiple functions of 
serotonin) remains to be determined. I think the authors based on the data presented needs to be a 
little more careful when interpreting the interconnection between GLP-1 and serotonin. This should 
also be reflected in the discussion.” 
 
-   We agree with Reviewer #1 and have now reformulated to make clearer that our statements in the 
highlights are speculative. We would, however, like to keep these interpretative statements, as they 
might attract a wider audience. 
 
“Overall, while it is impossible that GLP-1 and 5HT are interconnected there is no evidence in the 
current paper that this is the case.”   “Because GLP-1 and 5HT are both involved in appetite regulation 
does not automatically imply that the one systems works via the other.”    
 
We have altered the Discussion accordingly (section 4.4, pages 19 and 20). 
 
OTHER ISSUES:  
      
1)  “On Page 10 the authors give a long description of how they tested for the specificity of the 5-HT 
antibody: "We tested the specificity of the anti-5-HT antiserum by adsorbing it with a glutaraldehyde 
conjugate of 5-HT and keyhole limpet haemocyanin (KLH). To prepare the 5-HT-glutaraldehyde-KLH 
conjugate, 50 mg of KLH (Catalogue #H-2133, Lot #43H9524;" 
      “This entire section can be removed. 5HT staining is widely used and the use of a commercially 
antibody giving the correct pattern of staining is in my view sufficient documentation for specificity.” 
 
-  We have done as Reviewer #1 suggested and removed this section. 
 
2)  “Table 3 should be omitted and the antibodies and lot numbers could be included in the main text.” 
 
-  As suggested, we have removed Table 3 and included the information in the text of the revised 
manuscript. 
 
 
REVIEWER #2:  
 
“While the goals of the work are important and the YFP-PPG mouse valuable for a variety of 
experimental endpoints, enthusiasm for the MS is significantly diminished by the absence of 
quantification in light microscopic analysis, the small numbers of projections to neurons in target 
regions other than the caudal raphe, and the lack of additional knowledge about neurons that receive 
close appositions from YFP-PPG neurons (e.g., as noted by authors on P 16 line 16-17 regarding the 
tracing experiments required to reveal whether particular DMV neurons are enroute to affect to 
stomach versus pancreas).” 
 
-  We have added three new figures containing maps of neurons with and without close appositions 
from YFP-immunoreactive axons and quantification (see response to Reviewer #1). 
 
ADDITIONAL COMMENTS. 
 
“The authors note on P 14 line 38-39 that only EM can provide proof of functional contacts.  They then 
mention a finding from Pilowsky et al. that provides a perspective for their statement that half of the 
light microscopically determined terminals are revealed to make synaptic contacts based on EM 
analysis.  Given this rule of thumb, the general sparseness (all based on qualitative terms such as few, 
sparse, a very small number, etc) of YFP projections to ChAT and to TH neurons only served to further 
qualify conclusions that might be drawn from the present results.  In addition, given the concern about 
using instances of close apposition based on light microscopic data I am puzzled by the absence of 
quantifying their findings for each brainstem nucleus examined.” 
 
-  We have now added quantification in Figures 2, 4, and 6 - see response to Reviewer #1. 
 
“The 5-HT positive neurons of the caudal raphe receive qualitatively more YFP projections than other 
targets.  When talking about the possible functional meaning of such projections the authors conclude 
(in Abst.) that this connection may contribute to the regulation of appetite.  No further support or 
elaboration of it is made in the Discussion.  In addition, given the extensive literature on raphe pallidus 
contribution to brown fat thermogenesis, the hypothermic effect of central GLP-1R agonist, and YFP 
input to raphe pallidus revealed here, it was puzzling that no functional comments were made.” 
 
-  We have expanded on the possible link to thermogenesis, as suggested by Reviewer #2.  Please see 
section 4.4 of the Discussion in the revised manuscript (pages 19 and 20) . 
 
“The abstract and introduction state that PPG neurons produce the satiety peptide GLP-1.  Given the 
range of effects of GLP-1 including GI motility, incretin, cardiovascular and other effects to describe the 
peptide with this functional label is misleading.” 
 
-  We have changed the abstract accordingly. 
 
 
Dear Prof Lisberger, 
RE: NSC 12-587 
We submit for your consideration for publication in Neuroscience a revised version of our  
article entitled „Preproglucagon (PPG) neurons innervate neurochemically identified 
autonomic neurons in the mouse brainstem’ by Llewellyn-Smith, Gnanamanickam, 
Reimann, Gribble & Trapp. 
 
The manuscript has been modified on the basis of the suggestions of the Reviewers.  In 
particular, we have included 3 new figures in addition to the three figures in the original 
version of the manuscript.  The new figures document the distributions in the medulla of 
cholinergic, catecholaminergic and serotonergic neurons that receive or lack close 
appositions from YFP-PPG axons. 
 
We have uploaded colour versions of all 6 Figures.  If the revised manuscript is accepted for 
publication in Neuroscience, we would like all of the Figures to be published in colour 
online.  However, in print, Figures 2-5 should appear in black and white as colour 
reproduction is only essential for Figure 1.  In the revised manuscript, we have included two 
versions of the Figure Legends.  The Legends that should appear in the online version of the 
article (“Figure Legends (ONLINE VERSION)”, pages 21-24) describe the six figures in colour.  
The Legends that should appear in the print version of the article (“Figure Legends (PRINT 
VERSION)”, pages 24-26) describe the colour version of Figure 1 and the black and white 
versions of Figures 2-5. 
 
Thank you very much for your consideration.  We look forward to hearing from you about 
the manuscript in due course. 
 
Yours sincerely, 
 
Dr Stefan Trapp 
Department of Surgery and Cancer 
Imperial College London 
On behalf of the authors 
 
Cover Letter
Manuscript NSC-12-587 - Response to Reviewers 
 
We thank the Reviewers for their thorough evaluation of our manuscript and their helpful 
suggestions, which have improved the manuscript significantly. We now provide a revised 
manuscript that incorporates the suggestions of the Reviewers and hope that it is now 
acceptable for publication in Neuroscience. 
 
Below are our detailed responses to each point raised by the Reviewers: 
 
 
REVIEWER #1,  
 
1)  “The presentation of the data is inadequate. The data are important and the authors 
stress several times that the powerful immunohistochemistry of YFP has enabled them to 
view the complete brainstem PPG innervation. If this is indeed the case - and I must admit 
that the staining shown in Figs 1-3 is really clear - they should help the reader in 
understanding the full extent of this innervation. This could be done in a series of line-
drawings through the caudal brainstem (e.g. using images from mouse brain atlases) 
illustrating the location of 5HT, ChAT and TH cells (could even be illustrated on the same 
images) and the degree of innervation by PPG/YFP fibers. It is very difficult from the rather 
selected illustrations to get a full picture of the brainstem innervation and the extent to which 
the different phenotypically labeled neurons are contacted by the YFP fibers.” 
 
-  We have added three new figures to the revised manuscript (Figures 2, 4 and 6).  The new 
figures show maps of the distributions of TH-immunoreactive, ChAT-immunoreactive and 5-
HT-immunoreactive neurons in sections through various regions of the medulla. The maps 
indicate which neurons receive close appositions from YFP-immunoreactive varicosities and 
which do not and include counts of the neurons with and without appositions. The inclusion 
of three new figures in the revised manuscript has required us to add a section to 
Experimental Procedures describing how the maps were constructed and neurons were 
counted (section 2.2.1, “Mapping neurochemically-identified brainstem neurons that received 
or lacked YFP-immunoreactive innervation” on pages 10 and 11).  
      These new figures and the quantitative data have substantially strengthened the 
manuscript.  We thank Reviewer #1 for suggesting that we include such figures. 
 
2)  “The data are heavily overinterpreted: The two last highlights are overstatements that are 
not supported by the data”:  
      “The first statement is not supported by the data - and it certainly does not explain the 
cardiovascular effects of GLP-1 - well it could potentially be a route by which GLP-1 
influences the cardiovascular system, but the authors do not know if this is an important 
pathway.” 
      “The second statement is also heavily overinterpretation. Yes - GLP-1 is involved in 
appetite regulation and so is the serotonergic system, but if the two are connected and if the 
serotonergic neurons contacted by YFP fibers are involved in satiation (or one of the other 
multiple functions of serotonin) remains to be determined. I think the authors based on the 
data presented needs to be a little more careful when interpreting the interconnection 
between GLP-1 and serotonin. This should also be reflected in the discussion.” 
 
-   We agree with Reviewer #1 and have now reformulated to make clearer that our statements 
in the highlights are speculative. We would, however, like to keep these interpretative 
statements, as they might attract a wider audience. 
 
“Overall, while it is impossible that GLP-1 and 5HT are interconnected there is no evidence 
in the current paper that this is the case.”   “Because GLP-1 and 5HT are both involved in 
appetite regulation does not automatically imply that the one systems works via the other.”    
*Response to Reviews
 
We have altered the Discussion accordingly (section 4.4, pages 19 and 20). 
 
OTHER ISSUES:  
      
1)  “On Page 10 the authors give a long description of how they tested for the specificity of 
the 5-HT antibody: "We tested the specificity of the anti-5-HT antiserum by adsorbing it with 
a glutaraldehyde conjugate of 5-HT and keyhole limpet haemocyanin (KLH). To prepare the 
5-HT-glutaraldehyde-KLH conjugate, 50 mg of KLH (Catalogue #H-2133, Lot #43H9524;" 
      “This entire section can be removed. 5HT staining is widely used and the use of a 
commercially antibody giving the correct pattern of staining is in my view sufficient 
documentation for specificity.” 
 
-  We have done as Reviewer #1 suggested and removed this section. 
 
2)  “Table 3 should be omitted and the antibodies and lot numbers could be included in the 
main text.” 
 
-  As suggested, we have removed Table 3 and included the information in the text of the 
revised manuscript. 
 
 
REVIEWER #2:  
 
“While the goals of the work are important and the YFP-PPG mouse valuable for a variety of 
experimental endpoints, enthusiasm for the MS is significantly diminished by the absence of 
quantification in light microscopic analysis, the small numbers of projections to neurons in 
target regions other than the caudal raphe, and the lack of additional knowledge about 
neurons that receive close appositions from YFP-PPG neurons (e.g., as noted by authors on 
P 16 line 16-17 regarding the tracing experiments required to reveal whether particular DMV 
neurons are enroute to affect to stomach versus pancreas).” 
 
-  We have added three new figures containing maps of neurons with and without close 
appositions from YFP-immunoreactive axons and quantification (see response to Reviewer 
#1). 
 
ADDITIONAL COMMENTS. 
 
“The authors note on P 14 line 38-39 that only EM can provide proof of functional contacts.  
They then mention a finding from Pilowsky et al. that provides a perspective for their 
statement that half of the light microscopically determined terminals are revealed to make 
synaptic contacts based on EM analysis.  Given this rule of thumb, the general sparseness 
(all based on qualitative terms such as few, sparse, a very small number, etc) of YFP 
projections to ChAT and to TH neurons only served to further qualify conclusions that might 
be drawn from the present results.  In addition, given the concern about using instances of 
close apposition based on light microscopic data I am puzzled by the absence of quantifying 
their findings for each brainstem nucleus examined.” 
 
-  We have now added quantification in Figures 2, 4, and 6 - see response to Reviewer #1. 
 
“The 5-HT positive neurons of the caudal raphe receive qualitatively more YFP projections 
than other targets.  When talking about the possible functional meaning of such projections 
the authors conclude (in Abst.) that this connection may contribute to the regulation of 
appetite.  No further support or elaboration of it is made in the Discussion.  In addition, given 
the extensive literature on raphe pallidus contribution to brown fat thermogenesis, the 
hypothermic effect of central GLP-1R agonist, and YFP input to raphe pallidus revealed 
here, it was puzzling that no functional comments were made.” 
 
-  We have expanded on the possible link to thermogenesis, as suggested by Reviewer #2.  
Please see section 4.4 of the Discussion in the revised manuscript (pages 19 and 20) . 
 
“The abstract and introduction state that PPG neurons produce the satiety peptide GLP-1.  
Given the range of effects of GLP-1 including GI motility, incretin, cardiovascular and other 
effects to describe the peptide with this functional label is misleading.” 
 
-  We have changed the abstract accordingly. 
 
 
HIGHLIGHTS 
 
 GLP-1 neurons directly innervate brainstem cholinergic and monoaminergic neurons. 
 GLP-1 may influence satiety via heavy GLP-1 innervation of brainstem 5-HT neurons. 
 Innervation of dorsal vagal neurons underpins GLP-1’s role in control of digestion. 
 Central GLP-1 may affect cardiovascular control via GLP-1 inputs to C1 neurons. 
 
*Highlights (for review)
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ABSTRACT  
Preproglucagon (PPG) neurons produce glucagon-like peptide-1 (GLP-1) and occur 
primarily in the nucleus tractus solitarius (NTS). GLP-1 affects a variety of central autonomic 
circuits, including those controlling the cardiovascular system, thermogenesis, and most 
notably energy balance. Our immunohistochemical studies in transgenic mice expressing 
YFP under the control of the PPG promoter showed that PPG neurons project widely to 
central autonomic regions, including brainstem nuclei. Functional studies have highlighted 
the importance of hindbrain receptors for the anorexic effects of GLP-1. 
In this study, we assessed YFP innervation of neurochemically-identified brainstem 
neurons in transgenic YFP-PPG mice. Immunoreactivity for YFP plus choline 
acetyltransferase (ChAT), tyrosine hydroxylase (TH) and/or serotonin (5-HT) were visualised 
with two- or three-colour immunoperoxidase labelling using black (YFP), brown and blue-
grey reaction products. 
In the dorsal motor nucleus of the vagus (DMV), terminals from fine YFP-
immunoreactive axons closely apposed a small proportion of ChAT-positive and rare TH-
positive/ChAT-positive motor neurons, mostly ventral to AP. YFP-immunoreactive 
innervation was virtually absent from the compact and loose formations of the nucleus 
ambiguus. In the NTS, some TH-immunoreactive neurons were closely apposed by YFP-
containing axons. In the A1/C1 column in the ventrolateral medulla, close appositions on TH-
positive neurons were more common, particularly in the caudal portion of the column. A 
single YFP-immunoreactive axon usually provided 1-3 close appositions on individual 
ChAT- or TH-positive neurons. Serotonin-immunoreactive neurons were most heavily 
innervated, with the majority of raphé pallidus, raphé obscurus and parapyramidal neurons 
receiving several close appositions from large varicosities of YFP-immunoreactive axons. 
These results indicate that GLP-1 neurons innervate various populations of 
brainstem autonomic neurons. These include vagal efferent neurons and catecholamine 
neurons in areas linked with cardiovascular control. Our data also indicate a synaptic 
connection between GLP-1 neurons and 5-HT neurons, some of which might contribute to 
the regulation of appetite. 
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KEY WORDS 
 glucagon-like peptide 1, nucleus of the solitary tract, tyrosine hydroxylase, choline 
acetyltransferase, serotonin, green fluorescent protein 
 
 
 
 
HIGHLIGHTS 
 
 GLP-1 neurons directly innervate brainstem cholinergic and monoaminergic neurons. 
 GLP-1 may influence satiety via heavy GLP-1 innervation of brainstem 5-HT neurons. 
 Innervation of dorsal vagal neurons underpins GLP-1’s role in control of digestion. 
 Central GLP-1 may affect cardiovascular control via GLP-1 inputs to C1 neurons. 
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LIST OF ABBREVIATIONS 
5-HT Serotonin, 5-hydroxytryptamine 
AP Area postrema 
ChAT Choline acetyltransferase 
DAB Diaminobenzidine 
DMH Dorsomedial nucleus of the hypothalamus 
DMV Dorsal motor nucleus of the vagus 
GFP Green fluorescent protein 
GLP-1 Glucagon-like peptide 1 
Ig Immunoglobulin 
IRT Intermediate reticular nucleus 
KLH Keyhole limpet haemocyanin 
LPS Lipopolysaccharide 
NA Nucleus ambiguus 
NHS Normal horse serum 
NTS Nucleus of the solitary tract 
PPG Preproglucagon 
PPY Parapyramidal region 
PVN Paraventricular nucleus of the hypothalamus 
RVLM Rostral ventrolateral medulla 
TH Tyrosine hydroxylase 
YFP Yellow fluorescent protein 
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INTRODUCTION 
Glucagon-like peptide 1 (GLP-1) is an incretin that is released from enteroendocrine 
cells and facilitates absorption of nutrients (Holst, 2007). Like other gut peptides, such as 
cholecystokinin, GLP-1 is also synthesized by neurons within the central nervous system. 
GLP-1 is produced by post-translational processing of preproglucagon (PPG) and 
immunoreactivity for the products of PPG processing is found in many brain regions, with 
highest levels occurring in the dorsomedial (DMH) and paraventricular nucleus (PVN) of the 
hypothalamus and lowest levels in the cortex and hindbrain (Jin et al., 1988, Vrang et al., 
2007, Tauchi et al., 2008). Somata capable of synthesizing GLP-1, however, are restricted to 
the lower brainstem. The largest population of GLP-1-containing somata occurs in the caudal 
nucleus of the solitary tract (NTS) and there are also some cell bodies in the dorsomedial part 
of the medullary reticular nucleus (Jin et al., 1988, Larsen et al., 1997).  Similarly, in situ 
hybridisation has revealed PPG mRNA only in the caudal NTS, the intermediate reticular 
nucleus (IRT) and the olfactory bulb (Merchenthaler et al., 1999). Retrograde tracing has 
confirmed that the hypothalamic axons containing GLP-1 arise from the cell bodies in the 
NTS and IRT (Larsen et al., 1997, Vrang et al., 2007). 
Microinjection of GLP-1 or GLP-1 agonists into the brain has a multitude of effects, 
including suppression of food intake, control of blood glucose levels, nausea, changes in 
blood pressure and heart rate, as well as neuroprotection and effects on learning and memory 
(Tang-Christensen et al., 1996, Turton et al., 1996, Van Dijk et al., 1996, Thiele et al., 1998, 
Kinzig et al., 2002, Yamamoto et al., 2002, During et al., 2003, Cabou et al., 2008, Sandoval 
et al., 2008). Because of the functional importance of GLP-1 in the brain, we recently 
reinvestigated the distribution of central neurons capable of synthesizing GLP-1 using a 
transgenic mouse in which GLP-1 neurons express yellow fluorescent protein (YFP) 
throughout their cytoplasm under the control of the PPG promoter (Reimann et al., 2008). 
This approach allowed us to visualise PPG neurons and their processes with an 
unprecedented level of detail. Our study revealed the full distribution of PPG cell bodies and 
dendrites within the medulla and demonstrated that axons were widespread throughout the 
brain with the notable exception of cerebellum, hippocampus and cerebral cortex (Llewellyn-
Smith et al., 2011). These observations matched well with the distribution of GLP-1 receptors 
within the brain (Shughrue et al., 1996, Merchenthaler et al., 1999). Notably, we found 
varicose axons in many central sites that are involved in regulating autonomic functions. 
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GLP-1 released in these areas could contribute to the global and coordinated control of food 
intake, energy balance and maintenance of cardiovascular homeostasis. 
Recent functional studies have highlighted the importance of brainstem circuitry and 
brainstem GLP-1 receptors for physiological function (Yamamoto et al., 2003, Wan et al., 
2007a, Wan et al., 2007b, Hayes et al., 2008, Hayes et al., 2009, Holmes et al., 2009, 
Williams et al., 2009, Barrera et al., 2011) see also (Trapp and Hisadome, 2011) for review). 
These findings, together with the fact that our immunohistochemical study revealed many 
more varicose immunoreactive axons in the brainstem than previously reported, prompted us 
to define the innervation targets of PPG neurons within the brainstem in more detail. 
Catecholamine neurons in the area postrema (AP) have been shown to express GLP-1 
receptors (Yamamoto et al., 2003) and a subpopulation of cholinergic dorsal vagal motor 
neurons responds electrically to GLP-1 (Wan et al., 2007a, Wan et al., 2007b, Holmes et al., 
2009), consistent with these cell types receiving inputs from GLP-1 neurons. 
In this study, we used transgenic YFP-PPG mice (Reimann et al., 2008) in order to 
take advantage of the strong YFP expression that occurs throughout the cytoplasm of PPG 
neurons, including their terminals (Hisadome et al., 2010, Llewellyn-Smith et al., 2011).  To 
reveal GLP-1 innervation of cholinergic, catecholamine and serotonin neurons in the 
brainstem, we detected YFP-immunoreactivity in combination with immunoreactivity for 
choline acetyltransferase (ChAT), tyrosine hydroxylase (TH) or 5-hydroxytryptamine (5-HT), 
using two-colour or three-colour immunoperoxidase staining. 
 
2. EXPERIMENTAL PROCEDURES 
These studies were performed on 11 adult male and 11 adult female mGLU-124 
Venus YFP mice (Reimann et al., 2008), which will be referred to here as YFP-PPG mice.  
Mice were perfused at 12-16 weeks of age and weighed between 25 and 35g with males 
consistently being heavier than females of the same age. Mice were bred at Imperial College, 
kept on a 12 hour light:dark cycle and had unlimited access to food and water. All 
experiments were carried out in accordance with the UK Animals (Scientific Procedures) 
Act, 1986, with appropriate ethical approval. 
Mice under halothane anesthesia were given heparin (500 IU/l), flushed with 
phosphate-buffered saline to remove blood and perfused transcardially with 60 ml of 
phosphate-buffered 4% formaldehyde, pH 7.4.  Brains were post-fixed intact for 3 days at 
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room temperature on a shaker in the same fixative and then shipped to Flinders for sectioning 
and immunohistochemical staining. 
Blocks containing the brainstem were trimmed from the post-fixed brains and 
infiltrated with sucrose.  Three series of transverse 30m cryostat sections were cut from 
each block. Because we did not use a matrix to block the brains, the dorsoventral tilt of the 
sections varied among mice.  Consequently, Bregma values could not be reliably assigned to 
the brainstem sections studied here. 
2.1 IMMUNOHISTOCHEMISTRY 
Cryostat sections were first washed 3 x 10 min in 10 mM Tris, 0.9% NaCl, 0.05% 
thimerosal in 10 mM phosphate buffer, pH 7.4, (TPBS) containing 0.3% Triton X-100 and 
then exposed to TPBS-Triton containing 10% normal horse serum (NHS) for at least 30 min.  
TPBS-Triton containing 10% NHS was used to dilute primary antibodies; TPBS-Triton 
containing 1% NHS, to dilute secondary antibodies; and TPBS-Triton, to dilute the avidin-
horseradish peroxidase complex.  All steps in each protocol occurred on a shaker at room 
temperature and 3 x 10 min washes in TPBS were done after each incubation in an 
immunoreagent. 
Titration was used to determine the working concentrations of primary antibodies. 
Optimal dilutions produced the maximum number of immunoreactive structures with 
minimal non-specific background staining.  In the case of the anti-green fluorescent protein 
(GFP) antibody used to detect the YFP-expressing neurons, more dilute antibody was used to 
optimally visualize axons than for optimally visualizing cell bodies (see Llewellyn-Smith et 
al., 2011). We have previously shown that mouse tissue lacking GFP-expressing neurons 
shows no staining after immunoperoxidase processing to reveal GFP (Llewellyn-Smith et al., 
2011). 
After completion of the double or triple-labelling immunoperoxidase protocol 
detailed below, sections were mounted in serial order onto chrome alum-gelatine coated 
slides, dried and dehydrated. Coverslips were applied with Permaslip mounting medium 
(Alban Scientific, St Louis MO, USA). 
2.1.1. Two-colour Immunoperoxidase Labelling 
Double immunoperoxidase labelling was used to localise YFP-immunoreactivity 
with a black reaction product and either ChAT-, TH- or 5-HT-immunoreactivity with a brown 
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reaction product. After treatment with TBS-Triton and 10% NHS-TBS-Triton, the sections 
were transferred into 1:50,000 or 1:100,000 chicken anti-GFP (Catalogue #ab13970, Lot 
#623923; Abcam, Cambridge, UK) for 3-5 days.  After washing, the sections were exposed 
overnight to 1:500 biotinylated donkey anti-chicken immunoglobulin (Ig) Y (Catalogue 
#703-065-155, ; Jackson ImmunoResearch, West Grove PA) and then to 1:1,500 ExtrAvidin-
peroxidase (Sigma-Aldrich, St Louis MO, USA) for 4-6 hours.  Structures containing YFP-
immunoreactivity were stained black with a nickel-intensified diaminobenzidine (DAB) 
reaction in which peroxide was generated using glucose oxidase (Llewellyn-Smith et al., 
2005).  After a second blocking step in 10% NHS-TBS-Triton, sections were exposed to 
either 1:5,000 goat anti-ChAT (Catalogue # AB144P, Lot # 18110644 or JC1669317; 
Chemicon, Temecula, CA, USA), 1:5,000 rabbit anti-TH (Catalogue # AB152, Lot # 
LV1375881 or LV1532665; Chemicon) or 1:5,000 or 1:10,000 rabbit anti-5-HT (Catalogue 
#8250-0009, Lot #23073052; Biogenesis, Poole UK) for 2-3 days. Next, there was an 
overnight incubation in 1:500 biotinylated donkey secondary antibody directed against the 
immunoglobulin of the species in which the primary antibody was raised, i.e., donkey anti-
goat IgG (Catalogue #711-705-065-147; Jackson ImmunoResearch Laboratories Inc.,West 
Grove, PA, USA) or donkey anti-rabbit IgG (Catalogue #711-065-152; Jackson 
ImmunoResearch). After a final 4 hour incubation in ExtrAvidin-peroxidase, immunoreactive 
neurons were stained brown with an imidazole-intensified DAB reaction (Llewellyn-Smith et 
al., 2005). 
2.1.2 Three-colour Immunoperoxidase Labelling 
Triple immunoperoxidase labelling was used to localise YFP-, TH- and ChAT-
immunoreactivity in the same sections. After the two colour protocol was completed using a 
1:400,000 dilution of anti-GFP and a 1:5,000 dilution of anti-TH, an additional block with 
10% NHS-TBS-Triton was done and the sections were incubated first in 1:5,000 goat anti-
ChAT for 2-3 days, then in biotinylated anti-goat IgG overnight and finally in ExtrAvidin-
horseradish peroxidise for 4-6 hours. ChAT-immunoreactivity was localised with a Vector 
SG kit (Vector Laboratories, Burlingame, CA, USA) with reagents added to generate 
peroxide with glucose oxidase reaction (Llewellyn-Smith et al., 1999). 
2.1.3. Antibody Characterization 
In our previous study on YFP-PPG mice (Llewellyn-Smith et al., 2011), we 
demonstrated the specificity of the chicken anti-GFP antiserum used here.  We showed that 
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no staining occurred in sections from animals that lacked GFP-expressing neurons and that 
the anti-GFP antibody stained all of the neurons that fluoresced due to the presence of YFP. 
Sections of rat spinal cord stained with the goat anti-ChAT antiserum show the 
expected distribution of cholinergic neurons in the spinal cord (Fenwick et al., 2006).  When 
we have used recombinant rat ChAT (Chemicon Catalogue #Ag220) to adsorb this antiserum, 
we found no staining in tissue fixed and processed as here (Llewellyn-Smith et al., 2005). 
The supplier of the rabbit anti-TH antibody has used western blotting to check its 
specificity and obtained selective labelling of a single band at approximately 62kDa 
(reduced), which corresponds to TH. In sections from rats perfused and 
immunohistochemically processed as here using this anti-TH antibody, we have found that 
the medulla contains immunoreactive neurons with the expected morphologies and 
distributions and that the spinal cord contains axons with the expected distribution.  This 
antibody has been used extensively to study catecholaminergic innervation in the brain, 
spinal cord and periphery in a variety of species (e.g. (Cano et al., 2008, Nangle et al., 2009, 
Gnanamanickam and Llewellyn-Smith, 2011). 
We tested the specificity of the anti-5-HT antiserum by adsorbing it with a 
glutaraldehyde conjugate of 5-HT and keyhole limpet haemocyanin, which we prepared.  
Adsorbed and unadsorbed antibody solutions were incubated overnight at 4
o
C and used to 
immunoperoxidase stain 30 µm cryostat sections of formaldehyde-fixed rat and mouse 
medulla.  Overnight adsorption removed the vast majority of staining but did not completely 
abolish it.  Medulla sections stained with the adsorbed antiserum contained rare, faintly-
immunoreactive cell bodies in raphé pallidus and a few immunoreactive axons in the dorsal 
vagal complex compared to the usual distribution of immunoreactivity obtained with the 
unabsorbed antiserum. 
2.2. DATA COLLECTION AND ANALYSIS 
Immunoperoxidase-stained sections from the spinomedullary junction to the caudal 
end of the aqueduct were examined with an Olympus BH-2 brightfield microscope.  Cell 
bodies and proximal dendrites containing immunoreactivity for TH, ChAT or serotonin were 
examined for the presence of close appositions from YFP-positive axon terminals. An x100 
oil immersion lens was used to determine whether or not YFP-containing terminals were 
closely apposed to neurochemically-identified cell bodies and dendrites. YFP terminals lying 
side-by-side with an immunoreactive neuron were classed as closely apposed when there was no 
space visible between the terminal and the neuron.  In the case of terminals overlying immunoreactive 
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neurons, a close apposition was considered to be present when the terminal and the filled neuron were 
in focus in the same plane. 
A SPOT RT colour camera and SPOT RT software version 4.6 (Diagnostic 
Instruments Inc., Sterling Heights, MI, USA) were used to collect digital images from the 
sections as TIFF files. The sharpness, brightness, and contrast of the TIFFs were adjusted in 
Adobe PhotoShop, which was also used to colour match digital images. Montages of 
micrographs and plates containing micrographs were prepared using PhotoShop. 
2.2.1 Mapping neurochemically-identified brainstem neurons that received or lacked 
YFP-immunoreactive innervation 
To construct line drawings, a SPOT RT colour camera and an x10 objective were 
used to capture overlapping digital images through the dorsal vagal complex or ventral 
medulla on one side of the brainstem from each mouse. The micrographs from each section 
were saved as TIFF files, imported into Adobe Photoshop and montaged to create a single 
image of the region to be mapped.  A layer was added to the montage in PhotoShop and the 
surface of the medulla was traced with the pen tool.  Landmarks were traced with the pen tool 
on another layer.  Low magnification line drawings of each section were created from digital 
images taken with an x2 objective using a similar strategy. 
For recording the distribution of the each different neurochemical class of neuron 
that received or lacked appositions from YFP-immunoreactive varicosities on the line 
drawings, a separate layer was added to the TIFF file containing the x10 montage of each 
section. The position of each neuron was marked with a dot using the pencil tool and a 
different colour to represent each different type of neuron.  To count neurons with and 
without appositions, the layers with coloured dots were saved as individual TIFF files.  Each 
TIFF file was opened in ImageJ (National Institutes of Health) and the image was converted 
to black and white.  Dots were counted using the Analyze Particle function. 
Maps of DMV, AP and A2 neurons:  In the dorsal vagal complex from one female 
mouse, TH-immunoreactive neurons with and without YFP appositions and ChAT-
immunoreactive neurons with and without YFP appositions were mapped from every third 
section triple-stained for YFP, TH and ChAT (60 µm separating mapped sections).  A total of 
6 sections were mapped. The mapped region included most of the dorsal vagal complex 
ventral to AP.  However, YFP innervation was not assessed in the most caudal portion of the 
dorsal vagal complex because the dense accumulation of YFP-immunoreactive dendrites 
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made it impossible to determine whether close appositions were present on TH- or ChAT-
immunoreactive neurons. 
Maps of A1/C1 neurons:  TH-immunoreactive neurons with and without YFP 
appositions that lay in the A1/C1 column in the ventral medulla from one female mouse were 
mapped in every sixth section triple-stained for YFP, TH and ChAT (150 µm separating 
mapped sections).  A total of 13 sections were mapped.  The mapped region extended from 
the pyramidal decussation through the caudal portion of the facial nucleus. 
Maps of serotonin neurons: Ventral medullary 5-HT neurons with and without 
appositions from YFP-immunoreactive varicosities were mapped in every sixth section 
double-stained for YFP and 5-HT from one male mouse (150 µm separating mapped 
sections).  A total of 8 sections were mapped.  The mapped region extended from 
approximately the middle of AP to approximately the middle of the facial nucleus. 
Plates containing the maps were constructed in Adobe Illustrator. The layer 
containing the montage was deleted from the TIFF file for each section.  The resulting image 
was imported into Illustrator and the positions of all the neurons were remapped using larger 
symbols of different colours. 
3. RESULTS 
YFP-immunoreactive innervation of catecholamine neurons (Figures 1-4), 
cholinergic neurons (Figures 1 and 2), and serotonin neurons (Figures 5 and 6) in the 
brainstem was assessed in 11 adult male and 11 adult female YFP-PPG mice. After 
immunoperoxidase staining, YFP-PPG neurons in the NTS and IRT showed intense YFP-
immunoreactivity throughout their cell bodies and dendrites (Figures 1A-C, I and J).  In the 
brainstem, varicose axons arising from the YFP-PPG neurons were also very intensely 
stained for YFP.  The YFP-containing axons had clearly delineated varicosities and fine 
intervaricose segments (Figures 1 and 3).  Some of the axons had large varicosities; others 
had small fine varicosities and on some axons both large and small varicosities occurred (e.g., 
Figures 1G, 1J, 3B).  All three types of axons made close appositions on neurochemically-
identified brainstems neurons. 
The distribution of YFP-expressing neurons in the medulla of YFP-PPG mice was 
the same as reported previously (Llewellyn-Smith et al., 2011).  The largest group of YFP-
immunoreactive cell bodies occurred in the caudal lateral NTS and extended caudally from 
approximately mid-AP level past the caudal tip of AP (Figures 1A, F and I).  The second 
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major group of YFP-immunoreactive somata was located in the IRT, extending from about 
mid-AP to roughly where the NTS moved away from the fourth ventricle.  Triple labelling 
for GFP, TH and ChAT revealed that the YFP-PPG neurons in IRT lay dorsomedial to both 
the cholinergic neurons of the nucleus ambiguus (NA) and the noradrenergic neurons of the 
A1 cell group (Figure 1B). 
3.1. INNERVATION OF CATECHOLAMINE NEURONS BY YFP-IMMUNOREACTIVE 
PREPROGLUCAGON NEURONS 
Catecholamine neurons from the spinomedullary junction to the caudal end of the 
aqueduct were revealed by immunoreactivity for TH in transverse sections through the brains 
of 10 male and 7 female YFP-PPG mice (Figures 1 and 3).  In the medulla, TH-
immunoreactive neurons occurred in the ventrolateral medulla (A1/C1 cell group), the NTS 
(A2 cell group), the AP and around the midline in the dorsal medulla (C2 and C3 cell 
groups).  In the pons, TH-immunoreactive cell bodies were located around the exit of the 
facial nerve (A5 cell group) and in the locus coeruleus (A6 cell group). 
In the dorsal medulla, some of the TH-immunoreactive neurons of the A2 cell group 
in the NTS received close appositions from YFP-immunoreactive axons (Figures 1C-E and 
2). These appositions were more common in the region where YFP-immunoreactive cell 
bodies and dendrites formed a dense network throughout the NTS (Figure 2).  In AP, a small 
number of TH-immunoreactive cells were closely apposed by YFP-immunoreactive axons 
(Figures 1F-H and 2).  There were fewer TH-positive neurons with appositions in caudal AP 
than in rostral AP (Figure 2).  Throughout AP, the TH-containing neurons that received close 
appositions usually occurred near the lateral edge of AP or within the clusters of TH-positive 
neurons that lay on the dorsal surface of the most rostral portion of AP (Figure 2).  TH-
positive C2 and C3 neurons near the dorsal medullary midline received little YFP-positive 
innervation (not shown). 
As we have described previously, there was a moderate YFP-immunoreactive 
innervation of the rostral ventrolateral medulla (RVLM).  Boutons of YFP-positive axons in 
this region closely apposed the somata or proximal dendrites of some TH-immunoreactive C1 
neurons (Figures 3A-C and 4). Close appositions from YFP-immunoreactive axons also 
occurred on TH-positive neurons of the A1 cell group in the caudal ventrolateral medulla 
(Figure 4). Although rare on the most caudal A1 neurons near the spinomedullary junction 
(not shown), appositions from YFP-positive axons were common on TH-immunoreactive A1 
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neurons in the intermediate reticular region ventral to AP (Figure 4).  Near the caudal tip of 
the 4
th
 ventricle, TH-positive neurons in the rostroventral respiratory group also received 
close appositions from YFP-immunoreactive axons.  
In the ventral pons, YFP-immunoreactive varicosities closely apposed the somata or 
proximal dendrites of occasional TH-immunoreactive neurons of the A5 cell group. In the 
dorsal pons, TH-immunoreactive A6 neurons of the locus coeruleus formed a dense band of 
cell bodies (Figure 3D-F). Few YFP-immunoreactive axons penetrated the locus coeruleus 
region and the cell bodies of TH-positive A6 neurons only rarely received close appositions 
from YFP-positive boutons (Figure 3E, F). Many more varicose YFP-positive axons occurred 
within the neighbouring and more medially located Barrington’s nucleus (Figure 3E).  The 
TH-positive dendrites of A6 neurons penetrated the more heavily innervated area of 
Barrington’s nucleus but close appositions by YFP-immunoreactive varicosities were still 
rare on the dendrites that originated from the A6 neurons in locus coeruleus. 
In all of the TH-immunoreactive cell groups examined, innervated neurons generally 
received close appositions from 1-3 varicosities on a single YFP-immunoreactive axon. 
3.2. PREPROGLUCAGON INNERVATION OF CHOLINERGIC NEURONS 
Cholinergic neurons were revealed by the presence of ChAT-immunoreactivity in 
their cytoplasm. Transverse sections between the spinomedullary junction and the caudal end 
of the aqueduct were analysed from 4 male and 9 female YFP-PPG mice.  These sections 
contained major cholinergic cell populations in the hypoglossal nucleus, the dorsal motor 
nucleus of the vagus (DMV), NA, the facial nucleus and the abducens, pedunculopontine and 
tegmental nuclei. 
A relatively small proportion of the ChAT-immunoreactive DMV neurons were 
directly innervated by axons containing immunoreactivity for YFP (Figures 1I and J, 2).  
Near the spinomedullary junction, the DMV contained a moderate supply of varicose YFP-
immunoreactive axons. Nevertheless, at this most caudal level of the DMV, only occasional 
ChAT-positive dorsal vagal motor neurons received close appositions.  PPG cell bodies 
marked by YFP-immunoreactivity were located more rostrally in the NTS beneath AP (see 
above).  At this level, a dense network of YFP-positive dendrites was present along the 
ventral aspect of the DMV. More DMV neurons in this region than rostrally or caudally 
appeared to receive close appositions from YFP-positive terminals but the network of YFP-
PPG dendrites may also have obscured some appositions.  Mapping ChAT-positive DMV 
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neurons with and without appositions from YFP-immunoreactive varicosities ventral to AP 
(Figure 2) showed that motor neurons receiving GLP-1 innervation were distributed 
throughout the subpostremal DMV.  Nevertheless, innervated neurons were most often 
encountered medially and ventrally in this portion of the nucleus.  Occasional DMV neurons 
rostral to AP were also closely apposed by YFP-containing terminals. In sections triple-
stained for YFP, TH and ChAT, YFP-immunoreactive appositions were present on a very 
small number of DMV neurons containing immunoreactivity for both ChAT and TH (not 
shown). When DMV neurons were innervated, it was usually by a single YFP-
immunoreactive axon that had 1-3 fine, small varicosities in close apposition to the ChAT-
positive neuron (Figure 1J). 
In contrast to the DMV, very few YFP-immunoreactive axons travelled through the 
hypoglossal nucleus and none closely apposed ChAT-positive hypoglossal motor neurons. A 
small population of neurons with faint ChAT-immunoreactivity was located ventral to the 
rostral NA close to the surface of the medulla. YFP-immunoreactive axons with fine 
varicosities made rare close appositions on these ventral cholinergic neurons. Although YFP-
containing axons ran amongst the cholinergic neurons of the loose portion of NA, no close 
appositions were found. The compact formation of NA was also virtually devoid of YFP-
immunoreactive axons. 
Few YFP-immunoreactive axons occurred in the facial nucleus. Close appositions 
were almost never encountered on ChAT-positive neurons in this region. The rare neurons 
that did receive YFP-immunoreactive input were mostly located in the most medial part of 
the facial nucleus. Similarly, the nucleus abducens was virtually devoid of YFP-
immunoreactive axons and close appositions were never found. Further rostral, cholinergic 
neurons in the trigeminal motor nucleus did not receive a YFP-positive innervation although 
YFP-containing axons traversed the lateral edge of the nucleus. However, rare ChAT-positive 
neurons of the laterodorsal tegmental nucleus received close appositions from YFP-
immunoreactive axons. Single close appositions from YFP-positive varicosities also occurred 
on the somata or proximal dendrites of occasional pedunculopontine tegmental neurons. 
3.3. PREPROGLUCAGON INNERVATION OF SEROTONIN NEURONS 
5-HT-immunoreactive neurons from the spinomedullary junction to the decussation 
of the superior cerebellar peduncle were revealed in transverse sections from 5 male and 5 
female YFP-PPG mice. The most caudal 5-HT-immunoreactive cell bodies were located in 
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raphé pallidus, raphé obscurus, the parapyramidal region (PPY) and along the ventral surface 
of the medulla (Figures 5 and 6).  The 5-HT-immunoreactive neurons on the ventral surface 
first appeared in the region of AP (beneath caudal AP in some mice and beneath rostral AP in 
others) and disappeared at about the level of the rostral edge of NA.  The 5-HT-positive PPY 
neurons were located just lateral to the pyramids and were roughly co-extensive 
rostrocaudally with the motor neurons of NA. The long axes of many of the serotonergic PPY 
cell bodies were oriented dorsoventrally (Figure 5B).  At the level of the caudal facial 
nucleus, the dorsoventrally-oriented cell bodies characteristic of PPY serotonin neurons 
transitioned into cell bodies with a predominantly mediolateral orientation, which were the 
serotonin neurons of raphé magnus. The dorsal raphé and pontine raphé nuclei contained the 
most rostral 5-HT-immunoreactive neurons examined. 
The serotonin-containing neurons in PPY and on the ventral medullary surface were 
the most densely innervated of any of the neurochemically-identified neurons in this study 
(Figures 5B, D, E and 6).  The cell bodies and proximal dendrites of almost all of these 
neurons received several close appositions from YFP-positive terminals.  In general, close 
appositions from YFP-immunoreactive axons were somewhat less common on neurons in 
raphé pallidus than on PPY neurons. However, for both raphé pallidus neurons and PPY 
neurons, the density of appositions was highest at the caudal end of their distributions and 
diminished rostrally (Figure 6). 
YFP-immunoreactive axons also travelled through raphé magnus and the dorsal and 
pontine raphé nuclei. In all of these locations, occasional 5-HT-immunoreactive neurons 
received close apposition from YFP-labelled varicosities but the majority of serotonin 
neurons in these locations did not receive YFP innervation. 
Overall, more 5-HT-immunoreactive neurons in the medulla were innervated than 
were cholinergic or catecholamine neurons and the majority of caudal medullary 5-HT-
positive neurons received close appositions from YFP-immunoreactive varicosities. The YFP 
innervation of individual serotonin neurons was also denser than the innervation of individual 
cholinergic or catecholamine neurons. Each innervated ChAT-positive or TH-positive neuron 
received between one and three close appositions from YFP-containing varicosities.  In 
contrast, 5-HT-immunoreactive somata in the caudal medulla often received at least twice 
this number of appositions. 
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4. DISCUSSION 
In this study, we used two- and three-colour immunoperoxidase labelling to assess 
the GLP-1 innervation of neurochemically-identified brainstem neurons in YFP-PPG mice 
(Reimann et al., 2008, Llewellyn-Smith et al., 2011). YFP expression in these mice is 
restricted to cells in which the PPG promoter is active (Reimann et al., 2008, Hisadome et al., 
2010).  Consequently, in these mice, YFP-immunoreactivity occurs exclusively in cells that 
synthesize PPG, the precursor for glucagon, as well as GLP-1, GLP-2 and oxyntomodulin 
(Holst, 2007).  As a result, YFP labels only pancreatic -cells that produce glucagon, 
enteroendocrine L-cells and populations of central neurons that produce GLP-1 and GLP-2 in 
equimolar amounts (Reimann et al., 2008).  Single-cell RT-PCR has demonstrated that the 
YFP-expressing cells in YFP-PPG mice still produce PPG mRNA and should therefore 
synthesize GLP-1 in addition to YFP (Hisadome et al., 2010, 2011). Here, in addition to 
revealing YFP, we visualized neurons releasing catecholamines or acetylcholine using the 
presence of immunoreactivity for enzymes involved in the synthesis of these 
neurotransmitters (TH and ChAT, respectively). Immunoreactivity for 5-HT was used to 
identify serotonin neurons.  We assumed that YFP-containing axon terminals found in close 
apposition to TH-, ChAT- or 5-HT-immunoreactive cell bodies or dendrites signified 
innervation. Whilst only electron microscopy can provide the ultimate proof for this 
assumption, work on other types of central autonomic neurons has shown that at least half of 
the terminals that form close appositions at the light microscope level make synaptic contacts 
at the ultrastructural level (Pilowsky et al., 1992).  
Of brainstem neurons containing immunoreactivity for TH, 5-HT or ChAT, 
serotonin neurons received the heaviest YFP innervation.  A high proportion of the 5-HT-
positive neurons in the parapyramidal region and on the ventral surface of the medulla 
received many close appositions from YFP-immunoreactive varicosities.  Appositions were 
also common on serotonin neurons in raphé pallidus and occurred on some neurons in caudal 
raphé obscurus.  In contrast, neurons in raphé magnus and the dorsal raphé nuclei were 
moderately to sparsely innervated. Amongst brainstem catecholamine neurons, a significant 
fraction of the TH-immunoreactive neurons in the A1/C1 column in the ventrolateral medulla 
received close appositions, with 1-3 varicosities on the same axon providing innervation to a 
soma or proximal dendrite. In contrast, only rare TH-immunoreactive neurons in the locus 
coeruleus received appositions from YFP-positive varicosities.  Of brainstem cholinergic 
neurons, only a subset of ChAT-positive neurons in the DMV received appositions from 
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YFP-containing axons. A small number of DMV cell bodies with appositions also contained 
immunoreactivity for TH. Cholinergic DMV neurons with appositions most commonly 
occurred at the same rostrocaudal level as the cell bodies and dendrites of YFP-PPG neurons. 
The remaining groups of brainstem cholinergic neurons, including those in NA and the 
hypoglossal nucleus, essentially lacked YFP innervation. All of the neuronal populations 
mentioned above as receiving close appositions from YFP-immunoreactive varicosities have 
been shown to express mRNA for the GLP-1 receptor (Merchenthaler et al., 1999). 
4.1. INNERVATION OF AREA POSTREMA 
Activation of GLP-1 receptors within the brainstem is associated with a number of 
physiological and pathophysiological effects. Pharmacological activation of GLP-1 receptors 
in the brainstem reduces gut motility (Holmes et al., 2009), mediates lipopolysaccharide-
induced anorexia (Grill et al., 2004), influences satiety elicited by gastric distension (Hayes et 
al., 2009) and causes hypothermia (Skibicka et al., 2009).  In AP, GLP-1 receptors reside 
primarily on catecholamine neurons (Goke et al., 1995, Merchenthaler et al., 1999), which 
exhibit Fos-immunoreactivity after intravenous administration of the GLP-1 receptor agonist 
exendin-4 (Yamamoto et al., 2002, Yamamoto et al., 2003).  Because the AP has an 
incomplete blood-brain-barrier, it has been suggested that these receptors are a ‘gateway’ 
through which GLP-1 from the circulation can influence central nervous function. However, 
our previous study demonstrated that YFP-PPG neurons send axons into AP (Llewellyn-
Smith et al., 2011) and we suggested that GLP-1 released from these axons, rather than 
circulating GLP-1, might activate at least some of the receptors in AP.  Indeed, our present 
results demonstrate that YFP-PPG neurons innervate catecholaminergic AP neurons although 
this innervation is relatively sparse.  It is therefore possible that both centrally-derived and 
peripherally-produced GLP-1 might activate receptors within AP. 
4.2. GASTRIC AND PANCREATIC FUNCTION 
Neurons in the DMV respond functionally to GLP-1 or its stable analogue exendin-
4. In vivo, activation of GLP-1 receptors in the DMV has been linked to a reduction in gut 
motility (Holmes et al., 2009).  In vitro, both gastric-projecting and pancreas-projecting 
dorsal vagal motor neurons alter their electrical activity in response to GLP-1 application 
(Wan et al., 2007a, Wan et al., 2007b, Holmes et al., 2009). In the presence of TTX, about 
40% of pancreas-projecting DMV neurons maintained their GLP-1 induced depolarisation, 
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and thus are expected to have GLP-1 receptors (Wan et al., 2007b). In agreement with these 
pharmacological data, we found that a subset of ChAT-immunoreactive neurons within the 
DMV had a sparse YFP-immunoreactive innervation.  Interestingly, DMV neurons with 
YFP-positive appositions often occurred near the medial portion of the nucleus, where we 
have previously identified neurons that express Fos in response to glucoprivation induced by 
2-deoxyglucose in rats (Llewellyn-Smith et al., 2012)  Furthermore, in rats, DMV neurons 
containing both TH- and ChAT-immunoreactivity project exclusively to the gastric corpus 
(Guo et al., 2001). In this study, we found that a very small number of DMV neurons with 
this neurochemistry received YFP-positive innervation. Despite these observations, tracing 
experiments will be required to determine whether the DMV innervation reported here 
specifically targets gastric- and pancreas-projecting neurons or neurons supplying other 
regions of the gastrointestinal tract or other organs. At the level of the DMV, GLP-1 appears 
to be excitatory (Wan et al., 2007b, Holmes et al., 2009). However, its effect on gastric 
motility is inhibitory, suggesting that non-adrenergic, non-cholinergic vagal postganglionic 
neurons are part of the circuitry that mediates the effects of GLP-1 at the level of the stomach 
(Travagli et al., 2006, Holmes et al., 2009). 
4.3. CARDIOVASCULAR CONTROL 
In this study, we found that YFP-PPG neurons innervated ventral medullopontine 
catecholamine cell groups, including A1, A5 and C1 neurons.  We found substantial numbers 
of YFP-positive axons throughout the rostrocaudal extent of the ventrolateral medulla and 
catecholaminergic A1 and C1 neurons clearly received close appositions. C1 neurons of the 
RVLM are important for regulation of blood pressure because they mediate sympathetic tone 
(Abbott et al., 2009, Marina et al., 2011, Schreihofer and Sved, 2011). It seems feasible to 
assume that the innervation of C1 neurons described here provides an anatomical substrate 
for at least some of the demonstrated cardiovascular effects of central GLP-1 administration 
(Yamamoto et al., 2002, Cabou et al., 2008, Hayes et al., 2008). Since catecholamine neurons 
in the A1 region project to the hypothalamus (Sawchenko and Swanson, 1982, Rinaman, 
2001), GLP-1 inputs to A1 neurons could influence cardiovascular homeostasis as well as 
other autonomic functions through an A1-hypothalamus pathway.  We also found that A5 
catecholamine neurons received input from YFP-immunoreactive axons.  GLP-1 input to A5 
neurons may also influence sympathetic control of blood pressure (Guyenet, 2006). In 
contrast to the C1, A1 and A5 neurons, catecholaminergic A6 neurons of the locus coeruleus 
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in the dorsal pons were almost completely without innervation from YFP-immunoreactive 
axons. This observation suggests that any influence of central GLP-1 on wakefulness and 
arousal (Sara, 2009) is unlikely to be mediated by locus coeruleus neurons. 
The innervation of Barrington’s nucleus by YFP-immunoreactive axons could have 
significance for the control of autonomic function.  This nucleus is important for the control 
of micturition (Sasaki, 2005) and viral tracing studies have shown that Barrington’s nucleus 
is also part of the circuitry that controls sympathetically innervated targets such as the kidney, 
spleen and brown adipose tissue (Cano et al., 2000, Cano et al., 2003). 
4.4. AUTONOMIC FUNCTIONS CONTROLLED BY SEROTONIN NEURONS 
We found here that GLP-1 axons heavily innervated the majority of 5-HT neurons in 
ventral regions of the medulla and also provided input to other serotonergic nuclei in the 
brainstem. Serotonin (5-HT) is important for the control of a variety of homeostatic 
processes, including energy balance, respiration and body temperature (Breisch et al., 1976, 
Ray et al., 2011). 
The strong innervation of 5-HT neurons in the ventral medulla might play an 
important role in the satiating effects of central GLP-1.  GLP-1 and 5-HT have both been 
implicated in the regulation of food intake (Tang-Christensen et al., 1996, Turton et al., 1996, 
Halford et al., 2010, Lam et al., 2010).  A role of 5-HT downstream of GLP-1 is suggested by 
the finding that 5-HT-receptor 2C knockout mice fail to show satiation after intraperitoneal 
administration of GLP-1 (Asarian, 2009).  Anorexia caused by lipopolysaccharide (LPS) is 
also likely to involve both GLP-1 signalling and 5-HT receptors (Langhans, 2007). LPS 
induces Fos-immunoreactivity in both GLP-1 neurons in the NTS (Rinaman, 1999) and in 
serotonin neurons of raphé pallidus, raphé magnus and dorsal and median raphé nuclei (Kopf 
et al., 2010).  Furthermore, both injection of the GLP-1 antagonist exendin-9 into the 4
th
 
ventricle (Grill et al., 2004) and intraperitoneal administration of the brain-penetrant 
serotonin 2C-receptor antagonist SB 242084 reduce anorexia evoked by LPS (Kopf et al., 
2010). Taken together with our observation that 5-HT immunoreactive neurons in raphé 
nuclei receive close appositions from the axons of GLP-1 neurons, these data might indicate 
that 5-HT neurons are also a downstream target of GLP-1 neurons involved in LPS-induced 
anorexia. 
GLP-1 might also affect thermoregulatory responses through an input to 5-HT 
neurons.  Pharmacogenetic suppression of electrical activity in serotonin neurons in vivo 
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causes hypothermia and a reduction in respiratory chemosensitivity (Ray et al., 2011). The 
effects of central GLP-1 on chemosensitivity have not been assessed, but activation of 
brainstem GLP-1 receptors has been shown to cause hypothermia (Hayes et al., 2008).  
Furthermore, blockade of hindbrain GLP-1 receptor with exendin-9 prevents CART-induced 
hypothermia (Skibicka et al., 2009). Innervation of raphé pallidus neurons could provide a 
link between central GLP-1 and thermogenesis, as 5-HT neurons in this region are known to 
stimulate neurons in sympathetic nuclei of the spinal cord, which in turn promote brown 
adipose tissue metabolism (Morrison et al., 2008). As the GLP-1 receptor is predominantly 
coupled to Gs (Thorens and Widmann, 1996), it remains to be determined if raphé pallidus 
neurons are inhibited by GLP-1 or if the hypothermic effects of central GLP-1 involve 
alternative neuronal circuits. 
4.5. CONCLUSIONS 
In summary, this study provides the first detailed description of the GLP-1 
innervation of neurochemically-identified monoamine and serotonin neurons in the 
brainstem.  Our observations create an anatomical scaffold for understanding the diverse 
array of autonomic functions affected by central GLP-1.  We expect that the information 
about the distribution of GLP-1 inputs to brainstem neurons presented here will provide a 
valuable guide for functional studies probing the roles of central GLP-1 neurons. 
 
ACKNOWLEDGMENTS 
This research was supported by grants from the Medical Research Council, UK 
[G0600928] to ST and the National Health & Medical Research Council of Australia (Project 
Grants 480414 and 1025031) to ILS, and Wellcome Trust Senior Research Fellowships 
(WT088357 and WT084210) to FMG and FR, respectively.  Lee Travis provided expert 
technical assistance. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Llewellyn-Smith et al.          21 
FIGURE LEGENDS (ONLINE VERSION) 
FIGURE 1. Three-colour immunoperoxidase labelling for YFP in YFP-PPG neurons 
(black), tyrosine hydroxylase (TH) in catecholamine neurons (brown) and choline 
acetyltransferase (ChAT) in cholinergic neurons (blue-grey) in transverse sections through 
the dorsal medulla of YFP-PPG mice.  A, Low magnification micrograph showing the cell 
bodies of black, YFP-immunoreactive PPG neurons in the nucleus of the solitary tract (NTS).  
These neurons lie lateral to the dorsal motor nucleus of the vagus (DMV) and the majority 
occur at the level of the area postrema (AP).  The dendrites of the YFP-PPG neurons in NTS 
extend dorsomedially and also run lateral to the hypoglossal nucleus (HGN) and along the 
border between the DMV and the HGN.  cc, central canal.  Bar, 100 µm. B, In the 
intermediate reticular nucleus (IRT), the black, YFP-immunoreactive cell bodies of PPG 
neurons are located dorsomedial to both the brown, TH-immunoreactive neurons of the A1 
cell group and the blue-grey, ChAT-immunoreactive neurons of the nucleus ambiguus (NA).  
Bar, 100 µm.  C, Low magnification micrograph showing the dorsal vagal complex at the 
level of the most rostral YFP-PPG neurons.  A collection of YFP-immunoreactive dendrites 
travels between the DMV and HGN.  Arrows, brown, TH-immunoreactive cell bodies that 
are shown at higher magnification in D and E.  Bar, 250 µm.  D and E, Single varicosities 
(arrows) of black, YFP-immunoreactive axons closely appose brown, TH-immunoreactive 
cell bodies in the NTS.  Bars, 20 µm.  F, Low magnification micrograph showing the AP near 
the level of the most rostral YFP-PPG neurons.  Arrow, a brown, TH-immunoreactive cell 
body near the surface of AP that is shown at higher magnification in G.  Bar, 100 µm.  G, A 
single varicosity (arrow) of a black, YFP-immunoreactive axon closely apposes the brown, 
TH-immunoreactive cell body in AP.  Bar, 10 µm.  H, At the surface of rostral AP, black, 
varicose, YFP-immunoreactive axons and black, varicose, YFP-immunoreactive dendrites are 
intermixed with brown, TH-immunoreactive dendrites arising from AP neurons.  Bar, 20 µm.  
I, Low magnification micrograph showing the DMV near the level of the most rostral YFP-
PPG neurons. Arrows J1 and J2, two blue-grey, ChAT-immunoreactive vagal motor neurons 
that are shown at higher magnification in J.  Bar, 100 µm.  J, Fine varicosities (arrows) of 
black, YFP-immunoreactive axons closely appose the blue-grey, ChAT-immunoreactive cell 
bodies of DMV neurons J1 and J2.  Bar, 20 µm. 
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FIGURE 2. Maps of sections through the dorsal vagal complex of a YFP-PPG mouse 
showing the distribution of ChAT-immunoreactive and TH-immunoreactive neurons with 
and without close appositions from YFP-immunoreactive varicosities.  Sections were triple-
stained to reveal YFP, TH and ChAT.  Every third section was mapped; maps are therefore 
separated by 60µm.  The most caudal section is at the top left of the figure and the most 
rostral section is at the bottom right.  TH-immunoreactive neurons in the nucleus tractus 
solitarius (NTS) and area postrema (AP) are represented by circles; and ChAT-
immunoreactive neurons, predominantly in the dorsal motor nucleus of the vagus (DMV), by 
diamonds.  TH-immunoreactive neurons that receive close appositions from YFP-
immunoreactive varicosities are shown in red; those that do not receive appositions are 
shown in blue. ChAT-immunoreactive neurons that receive close appositions from YFP-
immunoreactive varicosities are shown in gold; those that do not receive appositions are 
shown in green.  The cell bodies of YFP-PPG neurons are represented by white stars. 
Numerical values indicate the proportion of neurons in each region that received close 
appositions from YFP-immunoreactive varicosities.  The percentages of neurons that 
received YFP- immunoreactive appositions in each region are given in parentheses.  The 
asterisk indicates an area of the DMV in which appositions could not be assessed because the 
dendrites of YFP-PPG neurons were too dense.  cc, central canal; HGN, hypoglossal nucleus. 
 
FIGURE 3. Two-colour immunoperoxidase labelling for YFP in YFP-PPG neurons 
(black) and tyrosine hydroxylase (TH) in catecholamine neurons (brown) in transverse 
sections through the rostral ventrolateral medulla (RVLM) and dorsal pons of YFP-PPG 
mice.  A, Low magnification micrograph showing the RVLM. Arrows, brown, TH-
immunoreactive cell bodies that are shown at higher magnification in D and E.  py, pyramidal 
tract.  Bar, 100 µm.  B and C, Single varicosities (arrows) of black, YFP-immunoreactive 
axons closely appose brown, TH-immunoreactive cell bodies in the RVLM.  Bar in B, 10 
µm; bar in C, 20 µm.  D, Low magnification micrograph showing the region of the locus 
coeruleus (LC) and Barrington’s nucleus (Bar).  Left is medial and the ventricle appears at 
top left.  The region in Box E is shown at higher magnification in E.  Arrow F, a brown, TH-
immunoreactive neuron in the subcoeruleus region (SubC) that is shown at higher 
magnification in F.  Bar, 250 µm.  E, There are many black, varicose YFP-immunoreactive 
axons in Bar.  However, only a few, black, varicose YFP-immunoreactive axons travel 
amongst the brown, TH-immunoreactive neurons of LC.  Of all of the TH-immunoreactive 
cell bodies in this region of LC, only 6 received close appositions from YFP-immunoreactive 
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varicosities, one of which (lower right) is marked by an arrowhead.  There were no close 
appositions on the TH-immunoreactive dendrites of LC neurons that penetrated Bar.  Bar, 50 
µm.  F, A single varicosity (arrow) of a black, YFP-immunoreactive axon closely apposes the 
brown, TH-immunoreactive cell body in SubC.  Bar, 20 µm. 
 
FIGURE 4. Maps of sections through the ventral medulla of a YFP-PPG mouse showing 
the distribution of TH-immunoreactive neurons with and without close appositions from 
YFP-immunoreactive varicosities.  Sections were triple-stained to reveal YFP, TH and 
ChAT.  Every sixth section was mapped; maps are therefore separated by 150µm.  The most 
caudal section is at the top left of the figure and the most rostral section is at the bottom right.  
TH-immunoreactive neurons that receive close appositions from YFP-immunoreactive 
varicosities are represented by red circles; TH-immunoreactive neurons that do not receive 
appositions are represented by blue circles.  The cell bodies of YFP-PPG neurons are 
represented by white stars.  Numerical values indicate the proportion of neurons in each 
section that received close appositions from YFP-immunoreactive varicosities.  The 
percentages of neurons that received YFP- immunoreactive appositions in each section are 
given in parentheses.  The insets show the entire section from which each map was 
constructed, allowing the dorsoventral tilt of the section can be assessed.  FN, facial nucleus; 
IO, inferior olive; NAc, compact formation of the nucleus ambiguus; py, pyramidal tract; 
pyx, pyramidal decussation. 
 
FIGURE 5. Two-colour immunoperoxidase labelling for YFP in YFP-PPG neurons 
(black) and 5-HT in serotonin neurons (brown) in transverse sections through the caudal 
ventral medulla of YFP-PPG mice.  A, Low magnification micrograph showing the ventral 
medulla from the midline through the RVLM,  Arrows B and C, brown, groups of 5-HT-
immunoreactive cell bodies that are shown at higher magnification in B and C.  py, pyramidal 
tract.  Bar, 100 µm.  B, In the parapyramidal region (PPY), a cluster of serotonin-
immunoreactive cells bodies receives close appositions from many YFP-immunoreactive 
axons. Bar, 20 µm.  C, The cell bodies of two brown, 5-HT immunoreactive neurons in raphé 
pallidus (RPa) receive several close apposition from varicosities (arrows) of black, YFP-
immunoreactive axons.  Bar, 10 µm.  D, A black, YFP-immunoreactive varicosity (arrow) 
forms a close apposition on a brown, 5-HT immunoreactive cell body that lies near the 
ventral surface (VS) in PPY.  Bar, 10 µm.  E, Two black varicosities on the same YFP-
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immunoreactive axon (arrows) closely appose a brown, 5-HT-immunoreactive cell body in 
RPa.  Bar, 10 µm. 
 
FIGURE 6. Maps of sections through the ventral medulla of a YFP-PPG mouse showing 
the distribution of 5-HT-immunoreactive neurons with and without close appositions from 
YFP-immunoreactive varicosities.  Sections were double-stained to reveal YFP and 5-HT.  
Every sixth section was mapped; maps are therefore separated by 150µm.  The most caudal 
section is at the top left of the figure and the most rostral section is at the bottom right.  5-HT-
immunoreactive neurons that receive close appositions from YFP-immunoreactive 
varicosities are represented by red circles; 5-HT-immunoreactive neurons that do not receive 
appositions are represented by blue circles.  The cell bodies of YFP-PPG neurons are 
represented by white stars. Numerical values indicate the proportion of 5-HT-
immunoreactive neurons in different region or the entire mapped population that received 
close appositions from YFP-immunoreactive varicosities.  The percentages of neurons that 
received YFP-immunoreactive appositions are given in parentheses.  The insets show the 
entire section from which each map was constructed, allowing the dorsoventral tilt of the 
section to be assessed.  FN, facial nucleus; IO, inferior olive; NAc, compact formation of the 
nucleus ambiguus; py, pyramidal tract; RPa, raphé pallidus; VS, ventral surface.. 
 
 
FIGURE LEGENDS (PRINT VERSION) 
FIGURE 1. Three-colour immunoperoxidase labelling for YFP in YFP-PPG neurons 
(black), tyrosine hydroxylase (TH) in catecholamine neurons (brown) and choline 
acetyltransferase (ChAT) in cholinergic neurons (blue-grey) in transverse sections through 
the dorsal medulla of YFP-PPG mice.  A, Low magnification micrograph showing the cell 
bodies of black, YFP-immunoreactive PPG neurons in the nucleus of the solitary tract (NTS).  
These neurons lie lateral to the dorsal motor nucleus of the vagus (DMV) and the majority 
occur at the level of the area postrema (AP).  The dendrites of the YFP-PPG neurons in NTS 
extend dorsomedially and also run lateral to the hypoglossal nucleus (HGN) and along the 
border between the DMV and the HGN.  cc, central canal.  Bar, 100 µm. B, In the 
intermediate reticular nucleus (IRT), the black, YFP-immunoreactive cell bodies of PPG 
neurons are located dorsomedial to both the brown, TH-immunoreactive neurons of the A1 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Llewellyn-Smith et al.          25 
cell group and the blue-grey, ChAT-immunoreactive neurons of the nucleus ambiguus (NA).  
Bar, 100 µm.  C, Low magnification micrograph showing the dorsal vagal complex at the 
level of the most rostral YFP-PPG neurons.  A collection of YFP-immunoreactive dendrites 
travels between the DMV and HGN.  Arrows, brown, TH-immunoreactive cell bodies that are 
shown at higher magnification in D and E.  Bar, 250 µm.  D and E, Single varicosities 
(arrows) of black, YFP-immunoreactive axons closely appose brown, TH-immunoreactive 
cell bodies in the NTS.  Bars, 20 µm.  F, Low magnification micrograph showing the AP near 
the level of the most rostral YFP-PPG neurons.  Arrow, a brown, TH-immunoreactive cell 
body near the surface of AP that is shown at higher magnification in G.  Bar, 100 µm.  G, A 
single varicosity (arrow) of a black, YFP-immunoreactive axon closely apposes the brown, 
TH-immunoreactive cell body in AP.  Bar, 10 µm.  H, At the surface of rostral AP, black, 
varicose, YFP-immunoreactive axons and black, varicose, YFP-immunoreactive dendrites 
are intermixed with brown, TH-immunoreactive dendrites arising from AP neurons.  Bar, 20 
µm.  I, Low magnification micrograph showing the DMV near the level of the most rostral 
YFP-PPG neurons. Arrows J1 and J2, two blue-grey, ChAT-immunoreactive vagal motor 
neurons that are shown at higher magnification in J.  Bar, 100 µm.  J, Fine varicosities 
(arrows) of black, YFP-immunoreactive axons closely appose the blue-grey, ChAT-
immunoreactive cell bodies of DMV neurons J1 and J2.  Bar, 20 µm. 
 
FIGURE 2. Maps of sections through the dorsal vagal complex of a female YFP-PPG 
mouse showing the distribution of ChAT-immunoreactive and TH-immunoreactive neurons 
with and without close appositions from YFP-immunoreactive varicosities.  Sections were 
triple-stained to reveal YFP, TH and ChAT.  Every third section was mapped; maps are 
therefore separated by 60µm. The most caudal section is at the top left of the figure and the 
most rostral section is at the bottom right. TH-immunoreactive neurons in the nucleus tractus 
solitarius (NTS) and area postrema (AP) that receive close appositions from YFP-
immunoreactive varicosities are represented by black circles; TH-immunoreactive neurons 
that do not receive appositions are represented by grey circles.  ChAT-immunoreactive 
neurons, predominantly in the dorsal motor nucleus of the vagus (DMV), that receive close 
appositions from YFP-immunoreactive varicosities are represented by black diamonds with 
white centres; ChAT-immunoreactive neurons that do not receive appositions are represented 
by pale grey diamonds.  The cell bodies of YFP-PPG neurons are represented by white stars. 
Numerical values indicate the proportion of neurons in each region that received close 
appositions from YFP-immunoreactive varicosities.  The percentages of neurons that 
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received YFP- immunoreactive appositions in each region are given in parentheses.  The 
asterisk indicates an area of the DMV in which appositions could not be assessed because the 
dendrites of YFP-PPG neurons were too dense.  cc, central canal; HGN, hypoglossal 
nucleus. 
 
FIGURE 3. Two-colour immunoperoxidase labelling for YFP in YFP-PPG neurons and 
tyrosine hydroxylase (TH) in catecholamine neurons in transverse sections through the 
rostral ventrolateral medulla (RVLM) and dorsal pons of YFP-PPG mice.  A, Low 
magnification micrograph showing the RVLM. Arrows, TH-immunoreactive cell bodies that 
are shown at higher magnification in D and E.  py, pyramidal tract.  Bar, 100 µm.  B and C, 
Single varicosities (arrows) of black, YFP-immunoreactive axons closely appose TH-
immunoreactive cell bodies in the RVLM.  Bar in B, 10 µm; bar in C, 20 µm.  D, Low 
magnification micrograph showing the region of the locus coeruleus (LC) and Barrington’s 
nucleus (Bar).  Left is medial and the ventricle appears at top left.  The region in Box E is 
shown at higher magnification in E.  Arrow F, a TH-immunoreactive neuron in the 
subcoeruleus region (SubC) that is shown at higher magnification in F.  Bar, 250 µm.  E, 
There are many black, varicose YFP-immunoreactive axons in Bar.  However, only a few, 
black, varicose YFP-immunoreactive axons travel amongst the TH-immunoreactive neurons 
of LC.  Of all of the TH-immunoreactive cell bodies in this regions of LC, only 6 received 
close appositions from YFP-immunoreactive varicosities, one of which (lower right) is 
marked by an arrowhead.  There were no close appositions on the TH-immunoreactive 
dendrites of LC neurons that penetrated Bar.  Bar, 50 µm.  F, A single varicosity (arrow) of a 
black, YFP-immunoreactive axon closely apposes a TH-immunoreactive cell body in SubC.  
Bar, 20 µm. 
 
FIGURE 4. Maps of sections through the ventral medulla of a female YFP-PPG mouse 
showing the distribution of TH-immunoreactive neurons with and without close appositions 
from YFP-immunoreactive varicosities.  Sections were triple-stained to reveal YFP, TH and 
ChAT.  Every sixth section was mapped; maps are therefore separated by 150µm. The most 
caudal section is at the top left of the figure and the most rostral section is at the bottom 
right. TH-immunoreactive neurons that receive close appositions from YFP-immunoreactive 
varicosities are represented by black circles; TH-immunoreactive neurons that do not receive 
appositions are represented by grey circles. The cell bodies of YFP-PPG neurons are 
represented by white stars.  Numerical values indicate the proportion of neurons in each 
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section that received close appositions from YFP-immunoreactive varicosities.  The 
percentages of neurons that received YFP- immunoreactive appositions in each section are 
given in parentheses.  The insets show the entire section from which each map was 
constructed so that the dorsoventral tilt of the section can be assessed.  FN, facial nucleus; 
IO, inferior olive; NAc, compact formation of the nucleus ambiguus; py, pyramidal tract; 
pyx, pyramidal decussation. 
 
FIGURE 5. Two-colour immunoperoxidase labelling for YFP in YFP-PPG neurons and 5-
HT in serotonin neurons in transverse sections through the caudal ventral medulla of YFP-
PPG mice.  A, Low magnification micrograph showing the ventral medulla from the midline 
through the RVLM,  Arrows B and C, groups of 5-HT-immunoreactive cell bodies that are 
shown at higher magnification in B and C.  py, pyramidal tract.  Bar, 100 µm.  B, In the 
parapyramidal region (PPY), a cluster of 5-HT-immunoreactive cells bodies receives close 
appositions from many YFP-immunoreactive axons. Bar, 20 µm.  C, The cell bodies of two 5-
HT immunoreactive neurons in raphé pallidus (RPa) receive several close apposition from 
varicosities (arrows) of black, YFP-immunoreactive axons.  Bar, 10 µm.  D, A black, YFP-
immunoreactive varicosity (arrow) forms a close apposition on a 5-HT immunoreactive cell 
body that lies near the ventral surface (VS) in PPY.  Bar, 10 µm.  E, Two black varicosities 
on the same YFP-immunoreactive axon (arrows) closely appose a 5-HT-immunoreactive cell 
body in RPa.  Bar, 10 µm. 
 
FIGURE 6. Maps of sections through the ventral medulla of a male YFP-PPG mouse 
showing the distribution of 5-HT-immunoreactive neurons with and without close appositions 
from YFP-immunoreactive varicosities.  Sections were double-stained to reveal YFP and 5-
HT.  Every sixth section was mapped; maps are therefore separated by 150µm. The most 
caudal section is at the top left of the figure and the most rostral section is at the bottom 
right. 5-HT-immunoreactive neurons that receive close appositions from YFP-
immunoreactive varicosities are represented by black circles; 5-HT-immunoreactive neurons 
that do not receive appositions are represented by grey circles. The cell bodies of YFP-PPG 
neurons are represented by white stars. Numerical values indicate the proportion of 5-HT-
immunoreactive neurons in different region or the entire mapped population that received 
close appositions from YFP-immunoreactive varicosities.  The percentages of neurons that 
received YFP-immunoreactive appositions are given in parentheses.  The insets show the 
entire section from which each map was constructed so that the dorsoventral tilt of the 
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section can be assessed.  FN, facial nucleus; IO, inferior olive; NAc, compact formation of 
the nucleus ambiguus; py, pyramidal tract; RPa, raphé pallidus; VS, ventral surface. 
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